Mr. Reiner has over 30 years of experience in pharmaceutical research and development. As Chief Scientific Officer, he leads the advancement of Relief's pharmaceutical technologies and new product development. He has a strong track record in developing innovative solutions for oral and topical use, with expertise in organic drug synthesis, pharmaceutical process development, and analytical control. Mr. Reiner has authored numerous scientific publications and is the inventor or co-inventor of several patents covering synthesis processes, drug delivery technologies, and pharmaceutical compositions and formulations. Since joining APR Applied Pharma Research SA, a subsidiary of Relief, in 2000, he has played a key role in driving pharmaceutical innovation.

Mr. Reiner holds a Master's degree in Pharmaceutical Chemistry and Technology from the University of Pharmacy in Milan, Italy.